Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Loyola researchers discover congestive heart failure biological marker

07.06.2005


Journal of the American College of Cardiology study



A simple blood test can quickly identify what type of congestive heart failure (CHF) a patient has, improving diagnostic accuracy; eliminating the need for extensive diagnostic tests, such as heart muscle biopsy or exploratory surgery; and enabling the patient to be treated sooner, according to a study published in the June 7 Journal of the American College of Cardiology. After blood is drawn, the test results are ready in 15 minutes.
In the study, researchers at Loyola University Health System found significantly higher levels of the cardiac hormone, brain natriuretic peptide (BNP), in the blood of patients with one type of CHF, restrictive cardiomyopathy (RCMP), versus another type of CHF, constrictive pericarditis (CP).

"This is an important discovery because, while the symptoms are similar for both types of heart failure, the diagnosis, treatment and prognosis are very different," said lead author Dr. Fred Leya, professor of medicine/cardiology, Loyola University Chicago Stritch School of Medicine; and director, interventional cardiology and director, cardiac catheterization lab, Loyola University Health System, Maywood, Ill. "By examining the BNP level in congestive heart failure patients, we can quickly determine whether they have RCMP or CP. As a result, we can provide the appropriate treatment much sooner."



Five million people in the U.S. have CHF, where the heart weakens and becomes unable to pump adequate amounts of blood. When blood returning from the body to the heart is not pumped fast enough, it starts to back up into the lungs. CHF symptoms include shortness of breath, swollen legs, swollen liver and fatigue, which could also be signs of other conditions. Some CHF may go undetected for months, even years.

All people have some level of BNP, but the heart muscle releases excessive amounts of the hormone in response to heart failure. Therefore, as expected, CP and RCMP patients had higher levels of BNP than patients with a normal heart. Yet, RCMP patients had significantly elevated BNP levels compared to CP patients.

"The reason for this is because CP patients have a rigid or scarred pericardium – the sac-like membrane covering the heart," said Leya. "As a result, the chambers of the heart are "restrained," and cannot expand and fill with blood to function normally. When this happens, the heart muscle wall cannot stretch as much and release BNP." Left untreated, CP can be life-threatening, and a surgical procedure to remove part of the pericardium may be necessary.

With RCMP, the heart muscle stiffens so that not enough blood can enter the ventricles, the lower chambers of the heart. However, unlike with CP patients, the pericardium is not rigid or scarred. Therefore, higher levels of BNP can be more easily released. In some cases, early diagnosis and treatment can prevent further damage. In other cases, treatment is aimed at decreasing the workload of the heart. Eventually, a heart transplant may be necessary.

For the study, Leya and colleagues measured BNP levels in 11 patients suspected of having CP or RCMP. Five patients had RCMP and six had CP, as confirmed by hemodynamic assessment. "The mean plasma BNP levels of the RCMP group were four times that of the CP group," said Leya, who is developing a registry of patients to further expand the study.

Co-authors of the study with Leya are Dr. Dinesh Arab, Dr. Dominique Joyal, Krystyna M. Shioura, Dr. Bruce E. Lewis, Dr. Lowell H. Steen and Dr. Leslie Cho.

Joanne Swanson | EurekAlert!
Further information:
http://www.lumc.edu

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>